Hyperfine, Inc. (HYPR)
USD 0.69
(0.46%)
USD 0.69
(0.46%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 94.19 Million USD | -29.73% |
| 2022 | 134.05 Million USD | -33.79% |
| 2021 | 202.47 Million USD | 183.08% |
| 2020 | 71.52 Million USD | 133.97% |
| 2019 | 30.57 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 85.44 Million USD | -9.3% |
| 2024 Q2 | 76.61 Million USD | -10.34% |
| 2023 Q4 | 94.19 Million USD | -8.6% |
| 2023 FY | 94.19 Million USD | -29.73% |
| 2023 Q2 | 112.6 Million USD | -7.78% |
| 2023 Q1 | 122.1 Million USD | -8.91% |
| 2023 Q3 | 103.06 Million USD | -8.47% |
| 2022 Q4 | 134.05 Million USD | -9.63% |
| 2022 Q3 | 148.33 Million USD | -8.27% |
| 2022 FY | 134.05 Million USD | -33.79% |
| 2022 Q2 | 161.7 Million USD | -9.57% |
| 2022 Q1 | 178.82 Million USD | -11.68% |
| 2021 Q1 | 208.45 Million USD | 191.43% |
| 2021 FY | 202.47 Million USD | 183.08% |
| 2021 Q4 | 202.47 Million USD | 148.84% |
| 2021 Q3 | 81.36 Million USD | -60.93% |
| 2021 Q2 | 208.25 Million USD | -0.1% |
| 2020 FY | 71.52 Million USD | 133.97% |
| 2020 Q1 | - USD | 0.0% |
| 2020 Q4 | 71.52 Million USD | 0.0% |
| 2019 FY | 30.57 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -200.322% |
| BrainsWay Ltd. | 62.97 Million USD | -49.589% |
| Cerus Corporation | 197.74 Million USD | 52.364% |
| Envoy Medical, Inc. | 7.64 Million USD | -1132.971% |
| electroCore, Inc. | 16.38 Million USD | -474.84% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -1124.636% |
| IceCure Medical Ltd | 16.41 Million USD | -474.034% |
| Inogen, Inc. | 326.19 Million USD | 71.122% |
| OrthoPediatrics Corp. | 449.58 Million USD | 79.048% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -245.431% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -468.182% |
| MaxCyte, Inc. | 268.27 Million USD | 64.887% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -1063.336% |
| Nexalin Technology, Inc. | 3.63 Million USD | -2493.645% |
| Orthofix Medical Inc. | 925.31 Million USD | 89.82% |
| PAVmed Inc | 33.11 Million USD | -184.426% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 34.334% |
| RxSight, Inc. | 182.55 Million USD | 48.398% |
| Sight Sciences, Inc. | 166.65 Million USD | 43.475% |
| SI-BONE, Inc. | 230.42 Million USD | 59.119% |
| TELA Bio, Inc. | 78.04 Million USD | -20.694% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 62.606% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -777.903% |
| Acutus Medical, Inc. | 53.96 Million USD | -74.572% |
| Talis Biomedical Corporation | 98.34 Million USD | 4.211% |
| Spectral AI, Inc. | 10.69 Million USD | -781.023% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 56.918% |
| CVRx, Inc. | 115.22 Million USD | 18.251% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -60.582% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -2923.799% |
| Bioventus Inc. | 810.91 Million USD | 88.384% |
| Venus Concept Inc. | 93.65 Million USD | -0.582% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -266.177% |
| LivaNova PLC | 2.42 Billion USD | 96.123% |
| 908 Devices Inc. | 202.98 Million USD | 53.592% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 88.301% |
| Nemaura Medical Inc. | 14.56 Million USD | -546.828% |
| NeuroPace, Inc. | 107.65 Million USD | 12.496% |
| LENSAR, Inc. | 69.58 Million USD | -35.373% |
| Apyx Medical Corporation | 79.24 Million USD | -18.878% |
| Cutera, Inc. | 346.29 Million USD | 72.798% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -124.198% |
| BioSig Technologies, Inc. | 1.79 Million USD | -5139.099% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 65.193% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -120.808% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 97.509% |
| Axonics, Inc. | 719.92 Million USD | 86.915% |
| Outset Medical, Inc. | 313.8 Million USD | 69.981% |
| IRIDEX Corporation | 34.43 Million USD | -173.548% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 76.725% |
| IRadimed Corporation | 92.15 Million USD | -2.217% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -1692.901% |
| INVO Bioscience, Inc. | 20.88 Million USD | -350.976% |
| Telesis Bio, Inc. | 70.41 Million USD | -33.784% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 38.873% |
| Varex Imaging Corporation | 1.24 Billion USD | 92.462% |
| Quipt Home Medical Corp. | 247.4 Million USD | 61.926% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -911.805% |
| Pulmonx Corporation | 178.95 Million USD | 47.36% |
| Dynatronics Corporation | 25.94 Million USD | -263.134% |
| Modular Medical, Inc. | 13.8 Million USD | -582.255% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -778.149% |
| Semler Scientific, Inc. | 78.06 Million USD | -20.667% |
| InMode Ltd. | 863.28 Million USD | 89.088% |
| Bruker Corporation | 4.24 Billion USD | 97.784% |
| Cytosorbents Corporation | 53.26 Million USD | -76.864% |
| DexCom, Inc. | 6.26 Billion USD | 98.496% |
| Align Technology, Inc. | 6.08 Billion USD | 98.452% |
| Viveve Medical, Inc. | 25.91 Million USD | -263.52% |
| ZimVie Inc. | 1.2 Billion USD | 92.185% |
| Movano Inc. | 9.42 Million USD | -899.883% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 81.072% |
| Nexalin Technology, Inc. | 3.63 Million USD | -2493.645% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -60.582% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 90.112% |
| Profound Medical Corp. | 43.68 Million USD | -115.626% |
| Insulet Corporation | 2.58 Billion USD | 96.36% |
| enVVeno Medical Corporation | 48.63 Million USD | -93.686% |
| Surmodics, Inc. | 185.73 Million USD | 49.283% |
| iCAD, Inc. | 41.41 Million USD | -127.435% |
| Nuwellis, Inc. | 9.77 Million USD | -864.166% |
| Biotricity, Inc. | 5.94 Million USD | -1485.141% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 78.252% |
| Aethlon Medical, Inc. | 8.24 Million USD | -1042.362% |
| InspireMD, Inc. | 47.64 Million USD | -97.718% |
| PAVmed Inc. | 33.11 Million USD | -184.426% |
| BIOLASE, Inc. | 35.1 Million USD | -168.366% |
| Beyond Air, Inc. | 56.96 Million USD | -65.375% |
| FONAR Corporation | 214.24 Million USD | 56.032% |
| AxoGen, Inc. | 196.82 Million USD | 52.141% |
| Vivani Medical, Inc. | 45.79 Million USD | -105.688% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 66.529% |
| Inari Medical, Inc. | 674.23 Million USD | 86.029% |
| UFP Technologies, Inc. | 404.13 Million USD | 76.691% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -302.585% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -891.244% |
| Tenon Medical, Inc. | 6.34 Million USD | -1384.618% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -901.371% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 9.116% |
| AdaptHealth Corp. | 4.61 Billion USD | 97.961% |
| Sintx Technologies, Inc. | 15.36 Million USD | -513.075% |
| NanoVibronix, Inc. | 6.67 Million USD | -1311.432% |
| Quanterix Corporation | 425.01 Million USD | 77.836% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -911.805% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -75.329% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 94.605% |
| TransMedics Group, Inc. | 706.04 Million USD | 86.658% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -49.068% |
| NeuroMetrix, Inc. | 21.42 Million USD | -339.68% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 64.935% |
| Biomerica, Inc. | 9.25 Million USD | -917.927% |
| Bone Biologics Corporation | 3.73 Million USD | -2420.197% |
| AVITA Medical, Inc. | 144.33 Million USD | 34.738% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -1834.855% |
| Silk Road Medical, Inc | 265.3 Million USD | 64.495% |